TrialBMC psychiatry2025

Assessing the metabolic impact of aripiprazole versus risperidone in the treatment of schizophrenia: a randomized double-blind controlled clinical trial.

Ramyar Rahimi Darehbagh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.